Leaf & Herb · Leaf/Green
Quinoa Leaf
Moderate EvidenceCompound10 PubMed Studies
Hermetica Superfood Encyclopedia
Quinoa leaves (Chenopodium quinoa Willd.) are nutritionally superior to quinoa grain, delivering higher concentrations of protein, calcium, flavonoids (quercetin-3-O-glucoside, kaempferol-3-O-rutinoside), protocatechuic acid, and phytoecdysteroids that exert potent antioxidant, anti-inflammatory, and enzyme-inhibitory activities—with salt-stressed leaf extracts showing markedly enhanced acetylcholinesterase and tyrosinase inhibition relevant to neurodegenerative and hyperpigmentation disorders (PMID 39861139). Soluble dietary fibers isolated from quinoa leaves of multiple cultivars demonstrate significant DPPH/ABTS radical-scavenging capacity, bile acid–binding ability exceeding 30%, and beneficial gut microbiota shifts including increased Bifidobacterium and Lactobacillus abundance during in vitro fermentation (PMID 36596115).
Quinoa leaf (Chenopodium quinoa) is the nutrient-dense foliage of the quinoa plant, native to the Andean highlands of South America, particularly Peru, Bolivia, and Ecuador. Historically integral to Andean diets, these leaves are valued for their complete plant-based protein, rich vitamin and mineral content, and unique flavonoids, making them a powerful superfood for systemic health and vitality.
Hu et al. (2023) in Food Research International isolated soluble dietary fibers from leaves of multiple quinoa cultivars and demonstrated significant DPPH/ABTS radical-scavenging capacity, bile acid–binding ability exceeding 30%, and beneficial shifts in gut microbiota—including increased Bifidobacterium and Lactobacillus abundance—during in vitro fermentation (PMID 36596115). Slimani et al. (2025) in Pharmaceuticals reported that salt-stressed quinoa leaf extracts exhibited markedly enhanced bioactivity, with potent in vitro inhibition of acetylcholinesterase and tyrosinase supported by in silico molecular docking analyses, positioning these leaves as candidates for sustainable drug development targeting Alzheimer's disease and hyperpigmentation (PMID 39861139). Todorova et al. (2024) in Molecules quantified phytoecdysteroids—including 20-hydroxyecdysone—across selected plant species including Chenopodium quinoa and evaluated their spasmolytic effects on gastric smooth muscles, suggesting a mechanistic basis for the traditional gastrointestinal use of quinoa greens (PMID 39519789). Alzahrani et al. (2025) in Environmental Geochemistry and Health demonstrated that biochar application mitigated oxidative stress attributes and arsenic bioaccumulation in quinoa under combined arsenic and heat stress, underscoring the importance of cultivation conditions for leaf safety and phytochemical quality (PMID 41176751).
- Macronutrients: Complete plant-based proteins (all nine essential amino acids), Dietary fiber (soluble and insoluble) - Vitamins: Vitamin C - Minerals: Calcium, Magnesium, Iron, Copper, Zinc (trace) - Phytochemicals: Flavonoids (quercetin, kaempferol), Saponins, Polyphenols, Oligosaccharides
Quinoa leaf phenolic compounds—quercetin-3-O-glucoside, kaempferol-3-O-rutinoside, protocatechuic acid, and vanillic acid—exert antioxidant activity by donating hydrogen atoms to neutralize DPPH and ABTS free radicals and by chelating pro-oxidant transition metal ions (Fe²⁺, Cu²⁺), thereby interrupting Fenton-mediated lipid peroxidation cascades and protecting cellular membranes. These flavonoids further suppress NF-κB nuclear translocation and downstream pro-inflammatory cytokine expression (TNF-α, IL-6, IL-1β), while soluble dietary fibers from quinoa leaves bind bile acids in the gastrointestinal lumen—exceeding 30% binding capacity—thereby upregulating hepatic cholesterol 7α-hydroxylase (CYP7A1) and lowering circulating LDL-cholesterol (PMID 36596115). Phytoecdysteroids, particularly 20-hydroxyecdysone quantified in quinoa tissues, modulate gastric smooth muscle contractility through calcium channel modulation and exhibit anabolic signaling via the PI3K/Akt/mTOR pathway without binding androgen receptors (PMID 39519789). Salt-stressed leaf extracts demonstrate enhanced acetylcholinesterase inhibition through competitive binding at the catalytic anionic site and peripheral anionic site of AChE, as confirmed by molecular docking with binding energies comparable to reference inhibitors (PMID 39861139).
Current research on quinoa leaves is limited to in vitro studies measuring antioxidant capacity and nutritional analysis. No specific clinical trials have been conducted on quinoa leaf extracts in human subjects. Related quinoa seed studies show flavonoid bioaccessibility in simulated digestion models and ACE-inhibitory peptide activity in spontaneously hypertensive rats, but these findings cannot be directly extrapolated to leaf preparations. The evidence base remains preliminary and requires human clinical validation.
Quinoa leaves contain oxalates and saponins that may reduce bioavailability of calcium, iron, and zinc; blanching or boiling for 3–5 minutes significantly reduces these antinutritional factors. Individuals taking anticoagulant medications (e.g., warfarin) should exercise caution, as the vitamin K content in green leafy quinoa tissue may antagonize drug efficacy, and the high quercetin content may inhibit CYP3A4 and CYP2C9 enzymes, potentially altering the metabolism of substrates such as statins and NSAIDs. Quinoa leaves may accumulate heavy metals—particularly arsenic—under contaminated soil conditions; Alzahrani et al. (2025) documented significant arsenic bioaccumulation in quinoa tissues under stress, highlighting the importance of sourcing leaves from uncontaminated agricultural environments (PMID 41176751). Pregnant or breastfeeding individuals should consult a healthcare provider before consuming quinoa leaves in supplemental quantities, as phytoecdysteroid effects on hormonal signaling have not been fully characterized in these populations.
